December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
News headline image
Gogo issues year-end “report card” on critical new product initiatives.
From Gogo Business Aviation Ltd
Via GlobeNewswire
Tickers GOGO
News headline image
Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category
From Fractyl Health, Inc.
Via GlobeNewswire
Tickers GUTS
Texas Capital Bancshares Inc (NASDAQ:TCBI) Passes Minervini's SEPA Growth and Trend Screen ↗
Via Chartmill
Tickers TCBI
News headline image
Beamr 2026 Strategy and 2025 Highlights
From Beamr Imaging Ltd.
Via GlobeNewswire
Tickers BMR
News headline image
Mobilicom Announces New Design Win and Initial Order from United Arab Emirates–Based Arms Manufacturer
From Mobilicom Limited
Via GlobeNewswire
Tickers MOB MOBBW
News headline image
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
News headline image
Sonepar Kicks Off First-Ever National Customer Appreciation Month for Electrical Contractors
From Sonepar
Via GlobeNewswire
News headline image
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
From Cibus US LLC
Via GlobeNewswire
Tickers CBUS
News headline image
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Maze Therapeutics, Inc.
Via GlobeNewswire
Tickers MAZE
News headline image
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Sionna Therapeutics, Inc.
Via GlobeNewswire
Tickers SION
News headline image
Orion Group Holdings Awarded $86.3 Million U.S. Army Corps of Engineers Project
From Orion Group Holdings, Inc.
Via GlobeNewswire
Tickers ORN
News headline image
Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines
From Frontier Medicines
Via GlobeNewswire
News headline image
Seyond to Showcase Live RoboVan Demonstrations and Next-Generation LiDAR at CES 2026
From Seyond Inc
Via GlobeNewswire
News headline image
Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting
From Gyre Therapeutics Inc.
Via GlobeNewswire
Tickers GYRE
News headline image
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
From Crescent Biopharma, Inc.
Via GlobeNewswire
Tickers CBIO
News headline image
OTC Markets Group Welcomes FPX Nickel Corp. to OTCQX
From OTC Markets
Via GlobeNewswire
Tickers FPOCF OTCM TSX-V:FPX
News headline image
Mobix Labs Powers Up U.S. Defense Operations: Veteran Defense GM Takes the Helm; Bigger Military-Approved Facility Expansion Planned
From Mobix Labs, Inc.
Via GlobeNewswire
Tickers MOBX
News headline image
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages
From Tilray Brands, Inc.
Via GlobeNewswire
Tickers TLRY TSX:TLRY
News headline image
Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Apellis Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers APLS
News headline image
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
From MapLight Therapeutics, Inc.
Via GlobeNewswire
Tickers MPLT
News headline image
Investor Attention Is Focused On The Commodities Market Following The Situation In Venezuela ↗
Via Talk Markets
News headline image
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
Venerable Successfully Acquires Investment Adviser and Closes Reinsurance Transaction
From Venerable Holdings, Inc.
Via Business Wire
News headline image
A New Crypto Wallet Is Wagering Big On A China–Taiwan Conflict ↗
Via Stocktwits
Tickers USDC
News headline image
Bitcoin Reclaims $92,000 As Ethereum, XRP Spike 2% ↗
Via Benzinga
News headline image
Vantage Data Centers and Liberty Energy Announce Strategic Partnership to Develop and Operate One Gigawatt of Power Solutions for Next Generation Data Centers
From Liberty Energy Inc.
Via Business Wire
Tickers LBRT
News headline image
AMD&#39;s Gamer Boom Signals Trouble For Intel&#39;s Long-Held Lead ↗
Via Benzinga
Topics Artificial Intelligence
Tickers AMD INTC
Exposures Artificial Intelligence
News headline image
Nigeria Alternative Lending Databook Report 2025: Market to Grow by 14.2% to Reach $756.2 Million in 2025 - Forecast to 2029 - ResearchAndMarkets.com
From Research and Markets
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.